Michael Sarcone
Stock Analyst at Jefferies
(0.15)
# 4,466
Out of 5,135 analysts
10
Total ratings
25%
Success rate
-26.03%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Hold | $81 → $66 | $61.90 | +6.62% | 2 | Feb 12, 2026 | |
| AXGN Axogen | Maintains: Buy | $29 → $36 | $35.27 | +2.08% | 2 | Dec 4, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $190.82 | -26.63% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $4.65 | -56.99% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $27.72 | +242.71% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $121.00 | +3.31% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $6.97 | +43.47% | 1 | Mar 21, 2023 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $81 → $66
Current: $61.90
Upside: +6.62%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $35.27
Upside: +2.08%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $190.82
Upside: -26.63%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $4.65
Upside: -56.99%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $27.72
Upside: +242.71%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $121.00
Upside: +3.31%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $6.97
Upside: +43.47%